Epic Sciences’s DefineMBC laboratory developed liquid biopsy test has been designed to aid clinicians in the identification and classification of metastatic breast cancer.
In May, Epic Sciences released additional data demonstrating its efficacy and on 1 June, the company announced that it...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?